178 related articles for article (PubMed ID: 2974493)
21. [Transitory abnormal myelopoiesis of the monoblastic form in a newborn infant with Down's syndrome and liver cirrhosis].
Urano Y; Kondo M; Hayashi Y; Wakuya J; Nakata T; Tanaka K; Seo A
Ann Pathol; 1983 Dec; 3(4):337-9. PubMed ID: 6230084
[TBL] [Abstract][Full Text] [Related]
22. Morphological characteristics of leukemic blasts in acute leukemia in a patient of Down syndrome following transient abnormal myelopoiesis.
Sharma S; Pujani M; Pujani M; Chandra J
Indian J Pathol Microbiol; 2011; 54(3):647-8. PubMed ID: 21934253
[No Abstract] [Full Text] [Related]
23. Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders.
Shimada A; Hayashi Y; Ogasawara M; Park MJ; Katoh M; Minakami H; Kitoh T; Kojima S; Kawa K; Kimura H
Leuk Res; 2007 Sep; 31(9):1199-203. PubMed ID: 17055049
[TBL] [Abstract][Full Text] [Related]
24. Transient abnormal myelopoiesis followed by acute megakaryoblastic leukemia with extramedullary tumors. An autopsied case of Down's syndrome.
Nito T; Terashima K; Matsuda M; Imai Y; Yokoyama S; Hayashi T
Acta Pathol Jpn; 1983 Sep; 33(5):1027-39. PubMed ID: 6228108
[TBL] [Abstract][Full Text] [Related]
25. Down syndrome with myelodysplasia of megakaryoblastic lineage.
Henderson R; Spence L
Clin Lab Sci; 2006; 19(3):161-4. PubMed ID: 16910232
[TBL] [Abstract][Full Text] [Related]
26. Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.
Kojima S; Matsuyama T; Sato T; Horibe K; Konishi S; Tsuchida M; Hayashi Y; Kigasawa H; Akiyama Y; Okamura J
Blood; 1990 Dec; 76(11):2348-53. PubMed ID: 2147864
[TBL] [Abstract][Full Text] [Related]
27. Expression of megakaryocytic and myeloid markers in blasts of transient abnormal myelopoiesis in a stillbirth with Down syndrome: report of histopathological findings of an autopsy case.
Ishigaki H; Miyauchi J; Yokoe A; Nakayama M; Yanagi T; Taga T; Ohta S; Itoh Y; Ogasawara K
Hum Pathol; 2011 Jan; 42(1):141-5. PubMed ID: 20970166
[TBL] [Abstract][Full Text] [Related]
28. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
Simon JH; Tebbi CK; Freeman AI; Brecher ML; Green DM; Sandberg AA
Cancer; 1987 Nov; 60(10):2515-20. PubMed ID: 2959356
[TBL] [Abstract][Full Text] [Related]
29. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome.
Eguchi M; Sakaibara H; Suda J; Ozawa T; Hayashi Y; Sato T; Kojima S; Furukawa T
Br J Haematol; 1989 Nov; 73(3):315-22. PubMed ID: 2532535
[TBL] [Abstract][Full Text] [Related]
30. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome.
Sunami S; Fuse A; Simizu B; Eguchi M; Hayashi Y; Sugita K; Nakazawa S; Okimoto Y; Sato T; Nakajima H
Blood; 1987 Aug; 70(2):368-71. PubMed ID: 2955817
[TBL] [Abstract][Full Text] [Related]
31. A case of pentasomy 21 with two isochromosome 21s in acute megakaryoblastic leukemia associated with Down syndrome.
Park Y; Lim J; Ko YH; Kim J; Kwon GC; Koo SH
Ann Lab Med; 2015 May; 35(3):373-5. PubMed ID: 25932450
[No Abstract] [Full Text] [Related]
32. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
33. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.
Kobayashi K; Usami I; Kubota M; Nishio T; Kakazu N
Cancer Genet Cytogenet; 2005 Apr; 158(2):184-7. PubMed ID: 15796967
[TBL] [Abstract][Full Text] [Related]
34. Trisomy 8 as a secondary genetic change in acute megakaryoblastic leukemia associated with Down's syndrome.
Ma SK; Lee AC; Wan TS; Lam CK; Chan LC
Leukemia; 1999 Mar; 13(3):491-2. PubMed ID: 10086746
[No Abstract] [Full Text] [Related]
35. Down syndrome-like acute megakaryoblastic leukemia in a patient with Cornelia de Lange syndrome.
Vial Y; Lachenaud J; Verloes A; Besnard M; Fenneteau O; Lainey E; Marceau-Renaut A; Preudhomme C; Baruchel A; Cavé H; Drunat S
Haematologica; 2018 Jun; 103(6):e274-e276. PubMed ID: 29217785
[No Abstract] [Full Text] [Related]
36. Acute megakaryoblastic leukemia preceded by refractory anemia with an excess of blast cells: leukemic transformation in an infant of Down syndrome recovering from transient abnormal myelopoiesis.
Yokoyama S; Nito T; Irimada K; Yoshimura Y; Hayashi T
Nihon Ketsueki Gakkai Zasshi; 1984 Feb; 47(1):62-70. PubMed ID: 6234741
[No Abstract] [Full Text] [Related]
37. GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.
Ariffin H; Garcia JC; Daud SS; Ibrahim K; Aizah N; Ong GB; Chong LA; Mohamad Z
Pediatr Blood Cancer; 2009 Jul; 53(1):108-11. PubMed ID: 19260099
[TBL] [Abstract][Full Text] [Related]
38. Acute megakaryoblastic leukemia in Down syndrome.
Hitzler JK
Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
[TBL] [Abstract][Full Text] [Related]
39. The treatment of children with acute megakaryoblastic leukemia who have Down syndrome.
Zipusky A
J Pediatr Hematol Oncol; 1996 Feb; 18(1):10-2. PubMed ID: 8556363
[No Abstract] [Full Text] [Related]
40. Comprehensive analysis of gene alterations in acute megakaryoblastic leukemia of Down's syndrome.
Hirose Y; Kudo K; Kiyoi H; Hayashi Y; Naoe T; Kojima S
Leukemia; 2003 Nov; 17(11):2250-2. PubMed ID: 12931214
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
